common.study.topics.clinical

Albuterol and Immune Cell Composition

common.study.values.description

Albuterol and Immune Cell Composition

The aim of this pilot study is to determine the effects of albuterol on the composition of immune cells in the bloodstream for possible future use in patients with neuroblastoma.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Administration of albuterol

Participants will inhale nebulized albuterol at a concentration of 2.5mg diluted in 3mL of normal saline for 20 minutes.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Albuterol and Immune Cell Composition

common.study.values.clinical-trial-id

NCT03889379

participant.views.study.view.id

dBBpWd